TTK Healthcare Completes Share Transmission from Deceased Promoters to Legal Heirs

1 min read     Updated on 29 Dec 2025, 05:58 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

TTK Healthcare Limited has successfully completed the share transmission process from deceased promoters Late Thiruvallur Thattai Jagannathan and Late Thiruvallur Thattai Venkatesh to their legal heirs. The transmission involves 7,73,298 shares being distributed among three beneficiaries, with regulatory compliance under SEBI LODR ensuring updated promoter group classification.

19742697

*this image is generated using AI for illustrative purposes only.

TTK Healthcare Limited has completed the transmission of shares from two deceased promoters to their legal heirs, marking the conclusion of a regulatory process that began following the deaths of key promoter group members.

Share Transmission Details

The company announced on December 29, 2025, that it has received intimation regarding the transmission of equity shares held by the deceased promoters. The transmission involves a total of 7,73,298 shares being transferred to three legal heirs:

Deceased Promoter: Category: Shares: Beneficiary: New Category: Shares Received:
Late Thiruvallur Thattai Jagannathan Promoter 7,59,298 Mukund Thiruvallur Thattai Promoter Group 2,53,099
Tiruvallur Thatai Lakshman Promoter Group 2,53,099
Sarayu Thiruvallur Thattai* Promoter Group 2,53,100
Late Thiruvallur Thattai Venkatesh Promoter Group 14,000 Sarayu Thiruvallur Thattai* Promoter Group 14,000

*Minor represented by her mother and natural guardian Mrs. Maitri Gopalakrishna

Regulatory Compliance and Classification Changes

Following the transmission, TTK Healthcare has made several regulatory disclosures under SEBI LODR Regulations. Ms. Sarayu Thiruvallur Thattai will now be classified as a person belonging to the Promoter Group in accordance with Regulation 31A(6)(a).

Under Regulation 31A(6)(c), both Late Thiruvallur Thattai Jagannathan and Late Thiruvallur Thattai Venkatesh will cease to be classified as Promoter and Promoter Group members, respectively.

Updated Shareholding Pattern

The company has confirmed that the updated and accurate Promoter and Promoter Group shareholding will be reflected in the Shareholding Pattern for the quarter ending December 31, 2025. This transmission process ensures continuity in the company's ownership structure while maintaining compliance with regulatory requirements.

The completion of this transmission process represents a significant milestone in TTK Healthcare's corporate governance, providing clarity on the promoter group composition following the earlier announced deaths of the promoter group members.

Historical Stock Returns for TTK Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.32%-3.86%-12.61%-30.36%-26.84%+47.84%

TTK Healthcare Appoints V Sundaresan as Additional Independent Director

2 min read     Updated on 22 Dec 2025, 01:22 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

TTK Healthcare Limited announced the appointment of V Sundaresan as Additional Independent Director following a board meeting on December 22, 2025. The appointment requires shareholder approval through postal ballot, with voting scheduled from December 25, 2025 to January 24, 2026. Sundaresan brings nearly four decades of financial leadership experience, having served as CFO of TTK Prestige Ltd. and held senior positions at General Electric and other organizations.

27935245

*this image is generated using AI for illustrative purposes only.

TTK Healthcare Limited has announced the appointment of V Sundaresan as Additional Independent Director, following a board meeting held on December 22, 2025. The appointment, recommended by the company's Nomination and Remuneration Committee, is subject to shareholder approval through a special resolution via postal ballot.

Director Appointment Details

The board approved Sundaresan's appointment for a five-year term effective December 22, 2025. The appointment details are outlined below:

Parameter: Details
Director Name: V Sundaresan
DIN: 11435475
Position: Additional Independent Director
Term: First term of 5 consecutive years
Effective Date: December 22, 2025
Approval Required: Shareholder approval via Special Resolution

Professional Background and Expertise

Sundaresan brings extensive financial leadership experience to the board. He is a commerce graduate from the University of Madras and a Fellow Member of the Institute of Chartered Accountants of India (FCA). His professional journey spans nearly four decades in finance, accounts, audit, and regulatory compliance.

His career highlights include senior positions at prominent organizations:

  • General Electric: Held senior financial positions
  • Greaves Cotton Co.: Leadership role in finance operations
  • BPL Refrigerators: Senior management position
  • TTK Group: Nearly three decades of service, retiring as Chief Financial Officer of TTK Prestige Ltd. in October 2020
  • Current Role: Partner with M/s Sowmya Sundaresan Co., Chartered Accountants

Key Professional Achievements

Sundaresan's expertise encompasses multiple areas of corporate finance and governance:

  • Led enterprise transformation through ERP implementation and data-driven decision-making
  • Played key roles in corporate restructuring, including demerger processes and overseas subsidiary establishment
  • Established comprehensive audit frameworks and internal controls as an active Risk Management team member
  • Developed profit-center accountability models to enhance operational efficiency
  • Oversaw organization-wide transition to GST and new Accounting Standards
  • Achieved significant improvements in working-capital cycles through analytics and fiscal discipline
  • Maintained strong relationships with investors and analysts

Postal Ballot Process and Timeline

The board has approved conducting a postal ballot process through remote e-voting for shareholder approval of the appointment. M/s AK Jain Associates, represented by partners Balu Sridhar and Anil Kumar Jain, has been appointed as scrutinizer for the process.

Complete Calendar of Events

Event: Date
Scrutinizer Consent: December 18, 2025
Board Meeting: December 22, 2025
Cut-off Date: December 19, 2025
Postal Ballot Notice Circulation: December 24, 2025
Newspaper Advertisement: December 25, 2025
Voting Commencement: December 25, 2025
Resolution Deemed Passed: January 24, 2026
Results Declaration: January 28, 2026
Minutes Signing Deadline: February 26, 2026

The board meeting commenced at 12:45 PM and concluded at 1:00 PM on December 22, 2025. The company has confirmed that Sundaresan is not disqualified or debarred from holding the office of Director pursuant to Section 164 of the Companies Act, 2013, or by virtue of any SEBI order or other authority. Sundaresan has no relationship with other directors and key managerial personnel of the company.

Historical Stock Returns for TTK Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.32%-3.86%-12.61%-30.36%-26.84%+47.84%

More News on TTK Healthcare

1 Year Returns:-26.84%